SCHEMBL3726876

SCHEMBL3726876

CCOC(=O)C(CCOC(=O)c1ccc(NC(=O)c2ccccc2-c2ccc(C(F)(F)F)cc2)cc1)(C(=O)OCC)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.48
ALDH1A1 P00352 5/20 0.48
GAA P10253 3/20 0.48
RAB9A P51151 3/20 0.48
NPC1 O15118 2/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
APOB P04114 5/20 0.45
MTTP P55157 8/20 0.45
MAPT P10636 4/20 0.44
TP53 P04637 1/20 0.44
MAPK1 P28482 1/20 0.43
LMNA P02545 1/20 0.43
GLA P06280 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27622150 0.91 SMN1; SMN2 (0.47) SMN1; SMN2ALDH1A1GAARAB9ANPC1
SCHEMBL3723677 0.89 APOB (0.47) SMN1; SMN2ALDH1A1GAARAB9ANPC1
SCHEMBL3727582 0.88 MTTP (0.48) SMN1; SMN2ALDH1A1GAAAPOBMTTP
SCHEMBL3737489 0.88 MTTP (0.56) ALDH1A1RAB9ANPC1MTTP
SCHEMBL3727619 0.87 SMN1; SMN2 (0.62) SMN1; SMN2ALDH1A1GAARAB9ANPC1
SCHEMBL3730634 0.86 MTTP (0.43) ALDH1A1APOBMTTP
SCHEMBL3727747 0.86 PDK2 (0.39) SMN1; SMN2GAARAB9ANPC1MTTP
SCHEMBL3730445 0.84 KDM4E (0.46) SMN1; SMN2GAAAPOBMTTP
SCHEMBL3725176 0.83 PPARG (0.47) ALDH1A1APOBMTTPL3MBTL1
SCHEMBL3731267 0.81 MTTP (0.46) SMN1; SMN2APOBMTTPMAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100158996-A1 ESTER COMPOUND AND MEDICAL USE THEREOF JAPAN TOBACCO INC. 2010-06-24 US claimed
US-20050075367-A1 Ester compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-04-07 US claimed
EP-1479666-A1 ESTER COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-11-24 EP claimed
US-20100158996-A1 ESTER COMPOUND AND MEDICAL USE THEREOF JAPAN TOBACCO INC. 2010-06-24 US disclosed
US-20100158996-A1 ESTER COMPOUND AND MEDICAL USE THEREOF JAPAN TOBACCO INC. 2010-06-24 US disclosed
US-20100158996-A1 ESTER COMPOUND AND MEDICAL USE THEREOF JAPAN TOBACCO INC. 2010-06-24 US disclosed
US-7625948-B2 Ester compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2009-12-01 US disclosed
US-7625948-B2 Ester compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2009-12-01 US disclosed
US-7625948-B2 Ester compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2009-12-01 US disclosed
US-20050075367-A1 Ester compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-04-07 US disclosed
EP-1479666-A1 ESTER COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050075367-A1 Ester compound and medicinal use thereof LIPC, CES1, MTTP SMN1; SMN2 4775/4885ALDH1A1 564/4885GAA 2055/4885
US-20100158996-A1 ESTER COMPOUND AND MEDICAL USE THEREOF LIPC, CES1, MTTP SMN1; SMN2 4782/4885ALDH1A1 603/4885GAA 1962/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.